OPKO Health Inc.

Regulatory Filings • Jan 8, 2024

OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference

MIAMI (January 8, 2024) – OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 42nd Annual J.P. Morgan Healthcare Conference, being held January 8-11, 2024 at Westin St. Francis hotel in San Francisco. Management will be hosting one-on-one meetings with investors and will be presenting on Wednesday, January 10th at 3:45 p.m. Pacific time.

The presentation will be webcast live and available for replay in the Investors section of OPKO Health's website here.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industryleading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

LHA Investor Relations Yvonne Briggs, 310-691-7100 ybriggs@lhai.com or Bruce Voss, 310-691-7100 bvoss@lhai.com

#